EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS092-21399 
Organism
Homo sapiens 
Tissue/cell
HFF 
Coordinate
chr17:80549160-80552090 
TF binding sites/motifs
Number: 19             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr17:80551231-80551249GGAGGGAGGGAGGGAGGG+6.03
EWSR1-FLI1MA0149.1chr17:80551235-80551253GGAGGGAGGGAGGGAGGG+6.03
EWSR1-FLI1MA0149.1chr17:80551250-80551268GGGAAAGAGGAAGGAAGG+6.14
EWSR1-FLI1MA0149.1chr17:80551254-80551272AAGAGGAAGGAAGGAAAG+6.23
EWSR1-FLI1MA0149.1chr17:80551239-80551257GGAGGGAGGGAGGGAAAG+6.31
EWSR1-FLI1MA0149.1chr17:80551258-80551276GGAAGGAAGGAAAGGAGA+6.82
EWSR1-FLI1MA0149.1chr17:80551227-80551245GGAAGGAGGGAGGGAGGG+7.12
EWSR1-FLI1MA0149.1chr17:80551223-80551241GGAAGGAAGGAGGGAGGG+7.97
EWSR1-FLI1MA0149.1chr17:80551219-80551237GGAAGGAAGGAAGGAGGG+9.72
KLF4MA0039.3chr17:80549241-80549252CCACACCCTGC+6.62
ZNF263MA0528.1chr17:80551255-80551276AGAGGAAGGAAGGAAAGGAGA+6.03
ZNF263MA0528.1chr17:80551256-80551277GAGGAAGGAAGGAAAGGAGAG+6.18
ZNF263MA0528.1chr17:80551244-80551265GAGGGAGGGAAAGAGGAAGGA+6.66
ZNF263MA0528.1chr17:80551220-80551241GAAGGAAGGAAGGAGGGAGGG+6.96
ZNF263MA0528.1chr17:80551236-80551257GAGGGAGGGAGGGAGGGAAAG+7.12
ZNF263MA0528.1chr17:80551224-80551245GAAGGAAGGAGGGAGGGAGGG+7.6
ZNF263MA0528.1chr17:80551240-80551261GAGGGAGGGAGGGAAAGAGGA+7.81
ZNF263MA0528.1chr17:80551232-80551253GAGGGAGGGAGGGAGGGAGGG+7.97
ZNF263MA0528.1chr17:80551228-80551249GAAGGAGGGAGGGAGGGAGGG+8.94
Number of super-enhancer constituents: 7             
IDCoordinateTissue/cell
SE_01005chr17:80548616-80552104Adrenal_Gland
SE_08753chr17:80547611-80552483Brain_Inferior_Temporal_Lobe
SE_23457chr17:80549045-80550903Colon_Crypt_1
SE_23457chr17:80551075-80552168Colon_Crypt_1
SE_24526chr17:80549996-80550760Colon_Crypt_2
SE_24526chr17:80551131-80552073Colon_Crypt_2
SE_31768chr17:80548538-80552181Gastric
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr178054944680549833
Enhancer Sequence
GGCCTCATTC AAACACAGGC GAGCCCATCC CTGGCCTGTC AGGTTCACCA GGGTGGCCCC 60
TGGTCCCGTT GTCGCCGTTG TCCACACCCT GCCCACCTGC CAATGCTCCT GTGTCCCCTG 120
CTCTGCTCCA GGGCCCCAAA CCCTGTGCAG AGCTGGGGTG CATCATGCTG CCGCCCCATG 180
GAGAAGGCCT GGAGGAGATG GAAGCCGGGA GGCTTCCTCT TACAGGAAGG GAAGCCCCAG 240
AAATGTGCCT GGCACCAAGA AACTGCTCCA AGCTTGTTCC AGAGTGTGGG GAGGGCTTGA 300
GGCCTCCCCT TTTTGAGTAC ATGGAAAGGA AAGCCTGGCA TTTTCTGGAA ACGCTCCCAA 360
GTCTCCCTGG CAGGGAGATG TGGGAAGAGT CCAGGCGCCC AAGCTCTTGC ATATTCACTT 420
CCTCCCATCA CACGTGCTGT GTACAAGCAC CCTCAGAGCT CGCTTTGGGA GACCCCTGCC 480
TCAGGGCTGC GGGTGCCGCC GTCCACACCA CAGGCCCTTC TGCTTCCTGT TTCCAAAGCT 540
CATCTCCTGT CTCTGGGCTG CAGGCGCTGT TTCTGGTTTA CTGGCACAAC TGTGGTTGTG 600
TTTTTGTCAA TGACTTCATC TTTGCTGCTG TTGTTTTGAG ATACTGTCTT GCTCTGTCAC 660
CCAGGCTGGA GTGCAGTGCC GAGATCTCAA CTCACTGCAG CCCCGACCTA CTGGTCTCAA 720
GCCATCCTCC TGCCTCAGCC TCCCAAGTAG CTGGGACTAC AGGTGTGCAG CACCACATCC 780
AGCTAAGTTT TTGTATTTTT TGTAGAGACA GGGTCTCACT ATGTTGCCCA GGCTGGTTTC 840
AAACTCCTGG ACTCTGGTGA TCCTCTAGCC TTGGCCTCCC AAAGTGCTGG GATTACAGGT 900
ACGAGCCAGC ATACCCAGCC AGTGTTGTCG TTTTGATTTG GGAGTTCGGG GCTGAGCTGT 960
GTTTGGCCAG GGCCTCGCCT GCTCAGTGTG CTCCTGGGCT GAGCTGCGGT CCTGGAGCAT 1020
CTCTTGGCTC ACATATTGAC TCCTCCGGCC TCTCTACTGT CCTGGTCCTT CATGGGGCTC 1080
ACATGTGTGT CCTCTTGTTT TCTTTCTGTC ACCTTCTTAA GGGTTCACAG ATCACTGTCA 1140
GTGGAAGGTG TTGCCACAGC TCAAGCCTCA CAGTGGAGGA ACCTCATGAG GCCCTTCACG 1200
GGGCCACTCC CTGTCTGGAC AGGCCTGCCT GACCAGCCCT GCTGGGAAGC CTGGGCTTTG 1260
CTGCTGCTTC ACCCTGCGAC ATTCTCCTCA GGCCCTGCCT TTCGCTTCTT TCGTTAACAT 1320
TGTTCCTGCC TTGATCGTTT GCTCCCTCCT GCCTAACTCT GCTCTTCTTC CTTGTGTAGC 1380
AGTTACGTGG TCCTCAAATA TCATTTGTTG ACTCCAGTGT TTCCTGGGGC ATCTCCTCAA 1440
GCTGGCTGGG GTTCTCTGCA TCTCAGCTGT GGCGCCTGGT GTGAGGGCGC ACGCTTCGCA 1500
GTGAGAGTGA AATGCCCAGT TCGCGCTGGC AGAGGGAGAC CCTGTGAAGG TCTCCCTGTG 1560
CCAGGCACAG GCTCTTATTC TGAAAGCAGA CCCCGTGAAG GTCTCCCTGT GCCGGGCACA 1620
GGCTCTTATT CTGAAAGTAG ACCCTGTGAA GGTCTCCCTG CGCCGGGCAC AGGCTCTTAT 1680
TCTGAAAGCA GACCCAGTGA AGGTCTCCCT GTACCGGGCA GAGGCTCTTA TTCTGAAAGC 1740
AGACCCCGTG AAGGTCTTCC TGTACCGGGC ACAGGCTCTT ATTCTGAAAG ACCCAGTGAA 1800
GGTCTCCCTG CGCCGGGCAC AGGCTCTTAT TCTGAAAGCA GACCCCGTGA AGGTCTCCCT 1860
GCACCGGGCA CAGGCTCTTA TTCTGAAAGC AGACCCAGTG AAGGTCTCCC TGTGCCAGGC 1920
AGAGGCTCTT ATTCTGAAAG CAGACCCAGT GAAGGTCTCC CTGTGCCAGG CAGAGGCTCT 1980
TATTCTGAAA GCAGACCCTG TGAAGGTCTC CCTGTACCGG GCACAGGCTC TTATTCTGAA 2040
AGGGTACGCA GCAGTTTCTG GAAGGAAGGA AGGAGGGAGG GAGGGAGGGA GGGAAAGAGG 2100
AAGGAAGGAA AGGAGAGCGA TAGGCACAGA GGAAGGTAGA TGAAGCCCCG CGCCCCCCTG 2160
GCGGAGCCCA GCCCTGTTCA CCGCGTGCTG TGCGGGTGCC TGTGCCAGGA TCAGCTGGCT 2220
GGACGGCTAT AGCCCCACGC CTGCAGGCCA CATACCTGGG AGAGTGTGGG CCTTCCGAGC 2280
CTTCTGGCTC CCGGCCCCAC AGAGGAATTA CGGTCCCATG TCCCTCACAA GGACCCTTGC 2340
AGAGGGAGCA GTGCATCGGC ACAGAGCAGG ACACAGGGGA GCCGGGCTGA GGCTGCGGGT 2400
CCCTTGTGGC CGCCAGGTGC TCACGCGTGC CTCGGTGGGG ATCTGGCAGC CAGATTTGGG 2460
GTGAGGATTT GATGATGTGG GTATCCCTAG CTGGTCCCAC AGTGACGATG GGTGTTGCGT 2520
TGTGAGCATG TAAAACGGCA GTGACGTCTG AGGGTCCCTG GACGTCTTTC ACACCCAGCC 2580
TCAAAGCGGA GCCTTTCCAG GCAGAGCAGC AGCTGCCGCC ACTGGATTGA CAGCCCCAGA 2640
GCAGCGGGAT CAGGCCACGC GGACGAGGAG GTGCGAGGCC TCGGGTCGGG GCCTGTGTTC 2700
TGCGGGAGCC GCACCCATCA TCGCTGTGGC GGTGGCAGTG GAGCAGCTGC TCTCGTGTCT 2760
GAGCTGCTCC GGCGTCTCTG TCCACAGTAT AGGGTCTTCT GATGCTTCCT GGAGGTCTCG 2820
GAGGGGCTTG CTGCGTGTAG TACCCACACA GCCCACAACT GGGGTGTTGT CAAGTGTTAT 2880
GACGTAGGTT GCCTGTGGAG TAAAAGTTGG CCGCTAAGAA ATGCTCTAGA 2930